Securian Asset Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,012
Closed -$981K 941
2024
Q1
$981K Sell
3,012
-100
-3% -$24.6K 0.03% 446
2023
Q4
$593K Hold
3,112
0.02% 634
2023
Q3
$620K Sell
3,112
-151
-5% -$35.7K 0.02% 579
2023
Q2
$931K Sell
3,263
-100
-3% -$27.8K 0.02% 492
2023
Q1
$729K Hold
3,363
0.02% 551
2022
Q4
$691K Hold
3,363
0.02% 566
2022
Q3
$935K Buy
3,363
+100
+3% +$25.4K 0.03% 457
2022
Q2
$624K Buy
+3,263
New +$576K 0.01% 628

Other funds holding SWAV

Securian Asset Management's SWAV Position: Q2 2024 in Review

Securian Asset Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 3,012 shares — an estimated $981K sold.

Securian Asset Management first reported a position in SWAV in Q2 2022 and held it in 8 quarters. The position peaked at $981K in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Securian Asset Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Securian Asset Management sold 3,012 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $981K.
  • Securian Asset Management first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2022 and held it in 8 quarters.
  • Securian Asset Management's Shockwave Medical, Inc. Common Stock position peaked at $981K in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Securian Asset Management's 13F filing for Q2 2024, filed 15 Jul 2024.